A Safety, Tolerability, and Pharmacokinetics (PK) Study of AGN-223575 in Healthy Subjects

Completed · Phase 1

Conditions studied: Healthy Volunteers

In brief

This study will evaluate the safety, tolerability, and pharmacokinetics (PK) of AGN-223575 in healthy subjects.

Key facts

Study ID

NCT02155543

Run by

Allergan

People needed

51

Starts

2014-05-01

Expected to finish

2015-01-01

Last updated by the study team

2016-04-12

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Weight at least 110 lbs

You may not qualify if…

• Use of contact lenses within 14 days, or planned use during the study
• Use of any ocular eye medications within 30 days, or anticipated use during the study
• Anticipated use of any artificial tears product during the study

Where it is running

• Study site — Newport Beach, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.